Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

BUY
$76.18 - $87.74 $16,835 - $19,390
221 Added 8.64%
2,778 $216,000
Q3 2022

Oct 14, 2022

SELL
$80.75 - $95.31 $4,360 - $5,146
-54 Reduced 2.07%
2,557 $206,000
Q2 2022

Jul 18, 2022

BUY
$87.4 - $113.09 $1,136 - $1,470
13 Added 0.5%
2,611 $234,000
Q1 2022

Apr 25, 2022

SELL
$100.58 - $112.38 $12,270 - $13,710
-122 Reduced 4.49%
2,598 $288,000
Q4 2021

Jan 25, 2022

SELL
$99.53 - $127.75 $115,355 - $148,062
-1,159 Reduced 29.88%
2,720 $281,000
Q3 2021

Oct 21, 2021

BUY
$122.75 - $135.17 $104,828 - $115,435
854 Added 28.23%
3,879 $486,000
Q2 2021

Jul 19, 2021

BUY
$118.19 - $131.5 $11,109 - $12,361
94 Added 3.21%
3,025 $375,000
Q1 2021

Apr 19, 2021

SELL
$111.18 - $119.74 $86,498 - $93,157
-778 Reduced 20.98%
2,931 $346,000
Q4 2020

Jan 14, 2021

SELL
$100.57 - $117.14 $30,975 - $36,079
-308 Reduced 7.67%
3,709 $434,000
Q3 2020

Oct 19, 2020

SELL
$90.13 - $108.78 $2,523 - $3,045
-28 Reduced 0.69%
4,017 $417,000
Q2 2020

Jul 28, 2020

SELL
$84.11 - $103.33 $117,669 - $144,558
-1,399 Reduced 25.7%
4,045 $371,000
Q1 2020

Apr 20, 2020

BUY
$72.92 - $121.3 $55,929 - $93,037
767 Added 16.4%
5,444 $491,000
Q4 2019

Jan 27, 2020

BUY
$104.49 - $114.54 $13,688 - $15,004
131 Added 2.88%
4,677 $531,000
Q3 2019

Oct 16, 2019

SELL
$98.02 - $111.18 $12,252 - $13,897
-125 Reduced 2.68%
4,546 $494,000
Q2 2019

Jul 08, 2019

SELL
$84.15 - $99.38 $16,745 - $19,776
-199 Reduced 4.09%
4,671 $455,000
Q1 2019

Apr 23, 2019

BUY
$82.45 - $93.79 $13,604 - $15,475
165 Added 3.51%
4,870 $444,000
Q4 2018

Jan 17, 2019

BUY
$85.8 - $99.49 $403,689 - $468,100
4,705 New
4,705 $428,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.